Literature DB >> 24739263

Increased levels of fatty acids contributed to induction of hepatic CYP3A4 activity induced by diabetes - in vitro evidence from HepG2 cell and Fa2N-4 cell lines.

Nan Hu1, Mengyue Hu, Ru Duan, Can Liu, Haifang Guo, Mian Zhang, Yunli Yu, Xinting Wang, Li Liu, Xiaodong Liu.   

Abstract

Accumulating evidences have shown that diabetes upregulated the function and expression of CYP3A4, but the mechanism remained unclear. In this study, HepG2 cells were incubated with serum from diabetic rats induced by streptozotocin, and the activity of CYP3A4 was measured by substrate metabolism. Results showed that incubation with diabetic serum significantly induced CYP3A4 activity in HepG2 cells. To identify the specific factors contributing to the regulation, the abnormally altered components in diabetic serum, including glucose, insulin, cholesterol, and free fatty acids were screened. It was found that only fatty acids concentration-dependently up-regulated CYP3A4 activity, and the induction by fatty acids was further confirmed in Fa2N-4 cells. Data from western blotting and QT-PCR showed that induction of CYP3A4 activity was associated with up-regulation of CYP3A4 protein and mRNA levels. In addition, effects of pharmacological inhibitors on fatty acid-induced CYP3A4 activity were studied. The results indicated that the induction of CYP3A4 activity by oleic acid may be partly via AMPK-, PKC-, and NF-κB-dependent pathways, whereas that by palmitic acid was possibly associated with the PKC-dependent pathway. In conclusion, the increased levels of fatty acids may be one of the reasons leading to the elevated function and expression of CYP3A4 under diabetic conditions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24739263     DOI: 10.1254/jphs.13212fp

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  8 in total

1.  Plasma Pharmacokinetic Determination of Canagliflozin and Its Metabolites in a Type 2 Diabetic Rat Model by UPLC-MS/MS.

Authors:  Song-Tao Dong; Hui-Min Niu; Yin Wu; Jia-Lei Jiang; Ying Li; Kun-Yu Jiang; Xin Wang; Mao-Fan Zhang; Ming-Feng Han; Sheng-Nan Meng
Journal:  Molecules       Date:  2018-05-20       Impact factor: 4.411

2.  Transcriptional Repression of CYP3A4 by Increased miR-200a-3p and miR-150-5p Promotes Steatosis in vitro.

Authors:  Zhijun Huang; Mengyao Wang; Li Liu; Jinfu Peng; Chengxian Guo; Xiaoping Chen; Lu Huang; Jieqiong Tan; Guoping Yang
Journal:  Front Genet       Date:  2019-05-28       Impact factor: 4.599

3.  Augmentation of Glucotoxicity, Oxidative Stress, Apoptosis and Mitochondrial Dysfunction in HepG2 Cells by Palmitic Acid.

Authors:  Arwa Alnahdi; Annie John; Haider Raza
Journal:  Nutrients       Date:  2019-08-22       Impact factor: 5.717

4.  A meta-analysis of genome-wide gene expression differences identifies promising targets for type 2 diabetes mellitus.

Authors:  Tao Huang; Bisma Nazir; Reem Altaf; Bolun Zang; Hajra Zafar; Ana Cláudia Paiva-Santos; Nabeela Niaz; Muhammad Imran; Yongtao Duan; Muhammad Abbas; Umair Ilyas
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-16       Impact factor: 6.055

5.  Pharmacokinetic Interaction between Atorvastatin and Omega-3 Fatty Acid in Healthy Volunteers.

Authors:  Jae Hoon Kim; Jung Sunwoo; Ji Hye Song; Yu-Bin Seo; Won Tae Jung; Kyu-Yeol Nam; YeSeul Kim; Hye Jung Lee; JungHa Moon; Jin-Gyu Jung; Jang Hee Hong
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-03

6.  The enhanced atorvastatin hepatotoxicity in diabetic rats was partly attributed to the upregulated hepatic Cyp3a and SLCO1B1.

Authors:  Nan Shu; Mengyue Hu; Zhaoli Ling; Peihua Liu; Fan Wang; Ping Xu; Zeyu Zhong; Binbin Sun; Mian Zhang; Feng Li; Qiushi Xie; Xiaodong Liu; Li Liu
Journal:  Sci Rep       Date:  2016-09-14       Impact factor: 4.379

Review 7.  Imbalance of Drug Transporter-CYP450s Interplay by Diabetes and Its Clinical Significance.

Authors:  Yiting Yang; Xiaodong Liu
Journal:  Pharmaceutics       Date:  2020-04-11       Impact factor: 6.321

Review 8.  Current trends in drug metabolism and pharmacokinetics.

Authors:  Yuhua Li; Qiang Meng; Mengbi Yang; Dongyang Liu; Xiangyu Hou; Lan Tang; Xin Wang; Yuanfeng Lyu; Xiaoyan Chen; Kexin Liu; Ai-Ming Yu; Zhong Zuo; Huichang Bi
Journal:  Acta Pharm Sin B       Date:  2019-10-18       Impact factor: 11.413

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.